Gapping down
Select oil/gas related names showing early weakness:
- TTE -2.5%, BP -1.2%, SHEL -1.1%
Other news:
- CRIS -35.4% (FDA places clinical hold on TakeAim Leukemia Phase 1/2a study)
- WVE -7.9% (Update to Ongoing Phase 1b/2a FOCUS-C9 Study Driven by Potent, Durable Reductions of Poly(GP) with Low, Single Doses of WVE-004)
- OCGN -5.2% (World Health Organization suspends Covaxin's supply through UN agencies, according to India Today)
- SBUX -2.8% (suspends stock buyback program)
- ALNY -1.9% (FDA has extended the review timeline of the New Drug Application for vutrisiran to allow for the review of newly added information related to the new secondary packaging and labeling facility)
- FREY -1.2% (announced the appointment of Oscar Brown to the position of Group Chief Financial Officer at FREYR Battery)
Analyst comments:
- HOLX -2.4% (downgraded to In-line from Outperform at Evercore ISI)
- BAX -2% (downgraded to Sell from Neutral at Goldman)
- CROX -2% (downgraded to Hold from Buy at Loop Capital)
- DGX -1.5% (downgraded to Neutral from Buy at Citigroup)
